Hamed Alavi - 18 Dec 2024 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Reporting relationship: Chief Technology Officer
Issuer ticker: NVNO
Reported as of: 18 Dec 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Dec 2024, 20:33:14 UTC
Prior SEC filing: 15 Mar 2024
Next SEC filing: 18 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Hamed Alavi

Key filing fact

Hamed Alavi filed Form 4 for enVVeno Medical Corp (NVNO) on 20 Dec 2024.

Key facts

This page summarizes Hamed Alavi's Form 4 filing for enVVeno Medical Corp (NVNO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Dec 2024, 20:33.

Change

Previous filing in this sequence was filed on 15 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVNO transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +75,000
Change %
Price: $0.000000
Shares after: 75,000
Date: 18 Dec 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 75,000
Exercise price: $2.57
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027.